doi: 10.1345/aph.1K182.
Epub 2007 Jul 31.
Alzheimer's disease: will advances made in the past turn the tide?
Affiliations
- PMID: 17666576
- DOI: 10.1345/aph.1K182
Item in Clipboard
Alzheimer's disease: will advances made in the past turn the tide?
Ann Pharmacother.
2007 Sep.
No abstract available
Similar articles
-
New drugs for Alzheimer's disease in Japan.Psychiatry Clin Neurosci. 2011 Aug;65(5):399-404. doi: 10.1111/j.1440-1819.2011.02253.x. Psychiatry Clin Neurosci. 2011. PMID: 21851448 Review. No abstract available.
-
Alzheimer disease and its management: a review.Am J Ther. 2006 Nov-Dec;13(6):516-26. doi: 10.1097/01.mjt.0000208274.80496.f1. Am J Ther. 2006. PMID: 17122533 Review.
-
Combination drug therapies for AD: progress is slow, but we must keep trying.Geriatrics. 2005 Jun;60(6):13-4. Geriatrics. 2005. PMID: 15948660 No abstract available.
-
[Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].MMW Fortschr Med. 2003 May 26;145 Suppl 2:21. MMW Fortschr Med. 2003. PMID: 14579479 German. No abstract available.
-
Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.Int J Geriatr Psychiatry. 2008 Sep;23(9):979-81. doi: 10.1002/gps.1979. Int J Geriatr Psychiatry. 2008. PMID: 18229874 Clinical Trial. No abstract available.
Cited by
-
Salivary tau species are potential biomarkers of Alzheimer's disease.J Alzheimers Dis. 2011;27(2):299-305. doi: 10.3233/JAD-2011-110731. J Alzheimers Dis. 2011. PMID: 21841250 Free PMC article.
-
Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.J Neurochem. 2019 Nov;151(4):397-416. doi: 10.1111/jnc.14635. Epub 2019 Jan 31. J Neurochem. 2019. PMID: 30474862 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
